Citadel Advisors’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,301
Closed -$141K 15556
2021
Q3
$141K Buy
+20,301
New +$178K ﹤0.01% 12453
2021
Q2
Sell
-13,514
Closed -$93K 15013
2021
Q1
$93K Buy
+13,514
New +$98.2K ﹤0.01% 12533
2019
Q4
Sell
-1,545
Closed -$11K 10177
2019
Q3
$11K Sell
1,545
-895
-37% -$5.96K ﹤0.01% 9038
2019
Q2
$18K Buy
+2,440
New +$18.2K ﹤0.01% 8964
2019
Q1
Sell
-4,393
Closed -$24K 10203
2018
Q4
$24K Buy
+4,393
New +$44.3K ﹤0.01% 8689
2018
Q3
Sell
-1,586
Closed -$30K 9974
2018
Q2
$30K Buy
+1,586
New +$27.4K ﹤0.01% 8569
2017
Q2
Sell
-1,784
Closed -$269K 8364
2017
Q1
$269K Buy
+1,784
New +$336K ﹤0.01% 6044
2015
Q3
Sell
-268
Closed -$71K 9419
2015
Q2
$71K Sell
268
-6,092
-96% -$1.46M ﹤0.01% 7410
2015
Q1
$1.26M Sell
6,360
-94
-1% -$15.3K ﹤0.01% 3642
2014
Q4
$941K Buy
+6,454
New +$931K ﹤0.01% 3844

Other funds holding FWP

Citadel Advisors's FWP Position: Q4 2021 in Review

Citadel Advisors sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q4 2021, closing a stake of 20,301 shares — an estimated $141K sold.

Citadel Advisors first reported a position in FWP in Q4 2014 and held it in 10 quarters. The position peaked at $1.26M in Q1 2015. 7 funds tracked by Wall St. Rank hold FWP as of Q4 2021.

  • Citadel Advisors reported no remaining Forward Pharma A/S American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Citadel Advisors sold 20,301 Forward Pharma A/S American Depositary Shares shares in Q4 2021, an estimated $141K.
  • Citadel Advisors first reported a position in Forward Pharma A/S American Depositary Shares in Q4 2014 and held it in 10 quarters.
  • Citadel Advisors's Forward Pharma A/S American Depositary Shares position peaked at $1.26M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.